Asthma PSP — ICS controller — Mixed ages — Nairobi, Kenya
Live
📷
Verified adherence
74%
↑ 8 pts vs program start
★
Activation rate
81%
↑ active this week
📋
90-day persistence
68%
↑ 11 pts vs baseline
⚠
At-risk patients
24
↓ 3 flagged today
📷
Dose logs
4,218
photo-verified ICS doses · this month
Baseline: 58%74% adherence
Adult
79%
Teen
71%
Child
69%
♿
Device returns
187
inhalers returned · photo-verified
Q1 target: 24078% of target
pMDI
94
DPI
61
Spacer
32
🙂
Mood logs
2,841
mood check-ins · this month
67% of active patients↑ 12% vs last month
Good
58%
Neutral
29%
Struggling
13%
Momentum — top streaks
Active patients
#
ID
Activity
Age
Pts
Streak
1
P-0044
Dose + return + mood
All 3 streams active
Adult
125K
🔥 28d
2
P-0078
Dose + mood
No return this month
Child
98K
🔥 21d
3
P-0201
Dose streak
Consistent dose only
Adult
84K
🔥 18d
4
P-0117
Dose + return
No mood logs
Teen
71K
🔥 14d
5
P-0289
Dose streak
Restarted after gap
Child
52K
🔥 9d
Points accumulate across all 3 streams · Lucky Spin triggers at milestones
At-risk — action required
24 patients
P-0183
No dose photo — 8 days
Previously consistent · sudden drop
Adult
29%
Critical
P-0241
Caregiver not uploading
Child · 6 days silent
Child
33%
Critical
P-0097
Skipping every 2–3 days
Low mood + low doses
Teen
48%
High
P-0312
Dropped at day 28
Early lapse · now silent
Teen
51%
High
P-0158
Sporadic — 14 weeks
Mood: struggling ×3 this month
Adult
57%
High
Top 5 of 24 · mood signal included in risk score · age guides follow-up approach
📷
Verified adherence
74%
↑ 8 pts vs program start
★
Activation rate
81%
253 / 312 active this week
📋
90-day persistence
68%
212 / 312 still on therapy
⚠
At-risk patients
24
↓ 3 flagged today
ICS dose adherence by zone
Photo-verified
Westlands
83%
↑5%
Karen
78%
↑3%
Kilimani
74%
↑7%
Kasarani
66%
↓2%
Embakasi
57%
↓5%
By age cohort
Child (under 12)
69%
84 patients · caregiver photo
↑ 14 pts vs baseline
Adolescent (12–17)
71%
96 patients · self-reported
↑ 9 pts vs baseline
Adult (18+)
79%
132 patients · self-reported
↑ 6 pts vs baseline
📷 Patients and caregivers self-report each ICS dose by photo. GPS-tagged and timestamped at capture. No PSP team required. Data Medical Affairs can trust.
Activation & 90-day persistence
312 patients
Activation rate
81%
active
253 / 312
Photo-verified dose this week
Active
253
Lapsed 7–14d
38
Lapsed 14d+
21
90-day persistence
68%
persist
212 / 312
Still on ICS at 90 days from enrolment
Persistent
212
Dropped 30–90d
59
Dropped <30d
41
🙂
Mood logs
2,841
67% of active patients
😁
Feeling good or great
58%
↑ 4 pts vs last month
😢
Struggling
199
68% also missed doses same week
📈
Mood → adherence lift
+58%
Great vs struggling adherence gap
Mood distribution — all patients
2,841 logs this month
Patients log mood daily in the app. For children, caregivers log on their behalf. Mood is a leading indicator — patients reporting "struggling" are 3× more likely to miss doses in the following week.
😁
Great
967
34%
🙂
Good
681
24%
😐
Neutral
625
22%
😑
Low
369
13%
😢
Struggling
199
7%
199 patients logged "struggling" this month
68% of these also missed at least one dose in the same week. Mood is the earliest flag the program has — it fires before the adherence data does.
✓ Daily self-report
✓ Caregiver proxy for under-12
✓ Adherence correlation tracked
Mood × adherence correlation
Next-day adherence rate by mood
Adherence rate the day after each mood state
😁
Great
89%
🙂
Good
82%
😐
Neutral
71%
😑
Low
54%
😢
Struggling
31%
Why mood matters to Medical Affairs
Mood is not a wellness add-on. A patient logging "struggling" today has a 69% chance of missing their dose tomorrow. This signal makes the PSP proactive, not reactive — and it's unique to platforms that capture wellbeing alongside adherence.
♿
Device return rate
78%
187 / 240 Q1 target
📷
pMDI canisters
94
↑ highest CO2e per unit
♿
DPI devices
61
↑ on track
⚠
Paediatric spacers
32
↓ below target
ICS inhaler returns by device type
Brand-agnostic · photo-verified
Patients return used ICS inhalers at pharmacy collection points found via the in-app map. Any brand accepted. Photo taken at drop-off, device weighed, entered into EPR waste manifest. Each return earns a Lucky Spin.
pMDI canisters
HFC propellant · ~2,000× CO2e warming potential · EPR priority
94
On track
DPI devices
Turbuhaler / Accuhaler · no propellant
61
On track
Paediatric spacers
Used with pMDI by under-12s · recovery rate low
32
Below tgt
Q1 EPR target vs actual
187 / 240 units
78% of quarterly target · pMDI recovery drives Scope 3 Cat. 12 impact
✓ Patient photo at drop-off
✓ Weight logged
✓ Waste manifest
✓ One-click EPR export
Monthly return trend
Units collected
Returned Target
Why pMDI recovery matters most
ICS pMDI canisters contain HFC propellants with ~2,000× the CO2e warming potential of CO2. Each canister recovered is a defensible Scope 3 Cat. 12 reduction — the only number your CSO can put in front of an auditor with a verified chain of evidence.
🎓
Knowledge index
72
↑ 19 pts vs enrollment
👥
Seminar attendance
68%
212 of 312 enrolled
✅
Quiz completion
81%
of attendees · pre & post
📈
Knowledge × adherence lift
+32%
0 vs 3+ seminars attended
Knowledge score by dimension
Pre vs post seminar
💊
ICS — why daily use matters
"My inhaler only works when I feel symptoms" — % who correctly disagree
79%
↑ 28 pts
Adult 84%
Caregiver 78%
Teen 71%
💨
Triggers & prevention
"Can you name 3 triggers that worsen your asthma?"
74%
↑ 22 pts
Adult 79%
Caregiver 76%
Teen 63%
🚨
Emergency red flags
"When would you go to hospital vs wait at home?"
61%
↑ 17 pts
Adult 68%
Caregiver 72%
Teen 44%
💉
Inhaler technique
"Correct technique observed during seminar check"
68%
↑ 31 pts
Adult 72%
Caregiver 74%
Teen 55%
♿
Device return & EPR reason
"Why does returning your inhaler matter for the planet?"
83%
↑ 41 pts
Adult 86%
Caregiver 84%
Teen 77%
✓ Pre/post quiz scored
✓ Observed technique check
✓ Medical Affairs exportable
Knowledge index
All 5 dimensions
72
/100
Informed
Emergency (61%) and technique (68%) need reinforcement — both safety-critical.
EPR / return
83%
ICS daily use
79%
Triggers
74%
Technique
68%
Emergency
61%
Next seminar — 18 March 2026
Lead with emergency red flags + technique. These are the two lowest scores and both are safety-critical.
Knowledge × adherence lift
By sessions attended
0 sessions
52%
n=41
1 session
63%
n=68
2 sessions
74%
n=89
3+ sessions
84%
n=114
At enrollment
53
avg. knowledge score
→
Today
72
+19 pts lift
Core impact claim
3+ seminar attendees show 84% adherence — 32 pts above those attending none. Knowledge is the strongest single predictor of sustained adherence in this program.
Monthly seminar history
Walk & Talk format · patients + caregivers
Month
Topic
Att.
%
Score
Oct 25
ICS — why daily use
Intro session · enrollment month
148
47%
51
Nov 25
Triggers & prevention
Dust, smoke, cold air, exercise
171
55%
58
Dec 25
Inhaler technique
Observed check + caregiver coaching
188
60%
64
Jan 26
Emergency red flags
When to go to hospital · rescue plan
196
63%
68
Feb 26
Device return & EPR
Why returns matter · Lucky Spin reminder
204
65%
71
Mar 26
Emergency + technique (repeat)
Today · 18 March 2026
212
68%
72
Score = weighted pre/post quiz average across all 5 dimensions · attendance rising each month
Sample question bank
30 questions · 5 dimensions · pre & post
ICS daily use
My controller inhaler should only be used when I have symptoms.
✕ True
✓ False — it reduces inflammation daily, even when symptom-free
Emergency red flags
Child's lips are blue, cannot speak in full sentences. You should:
✕ Give 2 puffs and wait 10 minutes
✓ Call emergency services immediately
Inhaler technique
How long should you hold your breath after inhaling from a pMDI?
✕ 2 seconds
✓ 10 seconds, then breathe out slowly
Device return & EPR
Why return your used inhaler rather than throwing it in the bin?
✕ To get a discount on the next one
✓ The HFC propellant is a powerful greenhouse gas — recovery prevents its release
Full bank
5 dimensions × 6 questions = 30 total. 3 given pre-seminar on arrival, 3 post at close. Score delta = knowledge lift per session. Caregiver version adapted for under-12 patients.
🌎
tCO2e avoided
9.4
est. from pMDI HFC recovery
♿
Devices recovered
187
↑ 38% vs Q4 2025
📷
Verified actions
7,059
doses + returns + mood
👥
Program reach
312
↑ 18 enrolled this month
Scope 3 coverage
Cat. 11 & 12
pMDI HFC propellant
78%
Inhaler packaging
71%
Device end-of-life
63%
Paediatric spacers
41%
Compliance frameworks
KEBS Medical Waste
84%
GHG Protocol Cat. 12
71%
IFRS S2 Disclosure
58%
Kenya EPR Device
78%
✓ ISAE 3000
✓ Audit trail
✓ GHG Protocol
ESG impact — CSO view
Q1 2026
Devices recovered
187
↑ 38% vs Q4
tCO2e avoided
9.4
est. pMDI HFC recovery
Verified doses
4,218
patient photo · ICS
Mood logs
2,841
wellbeing signal
Knowledge index
72
↑ 19 pts vs enrolment
Seminar attendees
212
68% of enrolled
What makes this defensible
Every data point is photo-captured by the patient or caregiver, timestamped, and GPS-tagged. The pharma lab receives a verified chain of evidence across four streams — adherence, device returns, patient wellbeing, and health literacy — that no other PSP platform generates simultaneously.
Lab reporting package
Ready to export
Verified adherence report
Per-patient · age cohort split · photo evidence · Medical Affairs ready
Patient wellness report
Mood distribution · adherence correlation · at-risk flags
Activation & persistence
Weekly activation rate · 90-day retention by cohort · dropout analysis
EPR device recovery log
Returns · device type · weight · waste manifest · KEBS format
Knowledge & impact report
Knowledge index · per-dimension scores · seminar attendance · pre/post lift
Scope 3 data pack
Cat. 11 & 12 · GHG Protocol · IFRS S2 · pMDI HFC breakdown
CSO ESG summary
tCO2e avoided · device return rate · program reach · one page